Login / Signup

Systemic adverse events after botulinum neurotoxin A injections in children with cerebral palsy.

Simon Paul PagetCaitlyn M SwinneyKaren L O BurtonKaren BauStephen J O'Flaherty
Published in: Developmental medicine and child neurology (2018)
Systemic adverse events occur in 3.6% of botulinum neurotoxin A (BoNT-A) injection episodes. Dysphagia and/or aspiration pneumonia are associated with increased likelihood of systemic adverse events. Multivariable models showed no evidence of association between Gross Motor Function Classification System and systemic adverse events. Multivariable models showed no evidence of association between BoNT-A dose and systemic adverse events.
Keyphrases
  • children with cerebral palsy
  • ultrasound guided
  • intensive care unit
  • drug induced
  • platelet rich plasma